Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2000
11/14/2000US6147093 Optically pure (+) isomer of norcisapride used for treatment of disorders caused by gastrointestinal motility dysfunction
11/14/2000US6147083 Novel substituted 1,2-ethanediamine derivatives which antagonize the pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins, useful for the treatment of asthma, etc.
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/14/2000CA1341139C Tetrahydropyridine oxime cholinergic agents and method of treatment
11/09/2000WO2000066579A1 Processes for the preparation of piperidylmethylpyridine derivatives
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066557A1 New compounds
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066550A1 New compounds
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000DE19920790A1 Bis-Sulfonamide mit anti-HCMV-Wirkung Bis-sulfonamides with anti-HCMV activity
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371215A1 New compounds
11/08/2000EP1050531A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049679A2 Sulphonamide derivatives for treatment of cns disorders
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049674A1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000CN1272843A Method for purifying 4-amino-piperidines
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/07/2000US6143918 Reacting a mixture of a 4,6-dibenzoylresorcinol and a para-aldehyde with a secondary amine catalyst and a carboxylic acid solvent and reacting the methylene carboxylate compound formed in step with an alcohol or a carboxylic acid
11/07/2000US6143896 Process for the alkylation of alkyl-or benzylcyanogen derivatives in the presence of trialkylamines or trialkylphosphines
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143744 Sulfamide-metalloprotease inhibitors
11/07/2000US6143541 Gene encoding a protein having symmetric hydrolase activity for 4-substituted 1,4-dihydropyridine derivatives and its expression product
11/07/2000CA2083913C Piperazinyl-and piperidinyl-cyclohexanols
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064866A1 Diphenylurea derivatives
11/02/2000WO2000064443A1 Synergistic effects of amlodipine and atorvastatin
11/02/2000WO2000064423A2 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000EP1048667A1 Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein
11/02/2000EP1048653A1 Donepezil polycrystals and process for producing the same
11/02/2000EP1048652A1 Aromatic compounds having cyclic amino or salts thereof
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047674A1 Process for production of donepezil derivatives
11/02/2000EP1047673A1 Novel heterocyclic compounds
11/02/2000EP1047670A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
11/02/2000CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
11/01/2000CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
10/2000
10/31/2000US6140502 Heat-based process for the re-racemisation of a (-)-2-phenylmethyl-3,3-dimethyl-piperidin-4-on derivative
10/31/2000US6140478 Suitable for coloring or printing especially of paper and leather.
10/31/2000US6140349 Cyclic amine modulators of chemokine receptor activity
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140333 For treatment and/or prophylaxis of diseases include such respiratory diseases as chronic obstructive pulmonary diseases, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema
10/31/2000US6140321 Polymorphs of donepezil hydrochloride and process for production
10/26/2000WO2000063173A1 Process for the preparation of substituted piperidines
10/26/2000WO2000063172A1 N-substituted piperidine derivatives
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000063157A1 Disubstituted benzene derivatives
10/26/2000WO2000035860A3 Acyl isothiocyanate resins and their use in solid-supported synthesis of guanidines
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/25/2000EP1046627A2 Enantiopure reagents and process for the separation of enantiomers
10/25/2000EP1045842A2 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
10/25/2000EP1045839A2 Novel amines as pharmaceutical agents
10/25/2000EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2000EP1045693A1 Aminophenoxyacetic acid derivatives as neuroprotectants
10/25/2000CN1271354A Compounds possessing neuronal activity
10/25/2000CN1057765C Preparing intermediate of 4-cyano-phenyl-imino-heterocyclic compound
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136981 Preparation of 4-phenyl-1,2,3,6-tetrahydropyridines
10/24/2000US6136969 Azepanes
10/24/2000US6136827 Cyclic amine modulations of chemokine receptor activity
10/24/2000US6136826 Aminopiperidine compounds substituted with alkanoyl
10/24/2000US6136824 1-piperidinyl-propan-2-derivatives and their use as therapeutic agents
10/21/2000CA2305944A1 Process for separating enantiomers and enantiopur reagent
10/19/2000WO2000061575A1 Process for the production of indole derivatives and intermediates therefor
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000WO2000061558A1 Remedies for neuropathic pain
10/19/2000WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000WO2000061552A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-α PRODUCTION INHIBITOR
10/19/2000WO2000061544A1 Method for preparing alkoxyamines from nitroxides
10/19/2000WO2000061148A1 Inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder
10/19/2000WO2000061125A2 Osanetant in the treatment of mood disorders
10/19/2000WO2000033788A3 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
10/19/2000CA2369695A1 Agent for treating neuropathic pain
10/19/2000CA2369691A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000CA2369666A1 N-substituted-n'-substituted urea derivatives and the use thereof as tnf-.alpha production inhibitory agents
10/19/2000CA2369638A1 Use of osanetant in the production of medicaments used to treat mood disorders
10/19/2000CA2369299A1 Inhibitor of visual function disturbance caused by optic nerve cell disorder due to factor other than ophthalmic circulatory disorder
10/19/2000CA2368829A1 Adamantane derivatives
10/19/2000CA2334845A1 Method for preparing alkoxyamines from nitroxides
10/18/2000EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
10/18/2000CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/18/2000CN1270580A Inhibition of pulp and paper yellowing using nitroxides and other coadditives
10/17/2000US6133456 Dimers of the macrocyclic natural product, fk506, covalently attached to each other via a synthetic linker moiety
10/17/2000US6133443 Optically active 1,4-dihydropyridine derivatives and process for the preparation thereof
10/17/2000US6133315 Administering to treat pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal; compounds such as 2-chlorobenzenesulfonic acid 3-(3-amidinopropoxy)-5-methylphenyl ester hydrochloride
10/17/2000US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension
10/17/2000US6132286 Preparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromide
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 380